Replies to post #175697 on Biotech Values

[Rocky3]

This is what makes a market and is one reason I think ENTA still has a lot of room on the upside.

Or ENTA is siginificantly overpriced if he is right about the size and/or duration of the ongoing market. Or if GILD is right that it can capture 90% of the market. As you say, that is what makes a market.